120 related articles for article (PubMed ID: 6295896)
1. A pharmacological approach to the inhibition of platelet adhesion and platelet aggregation. Wright-Schulte Lecture.
Verstraete M
Haemostasis; 1982; 12(4):317-36. PubMed ID: 6295896
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of action of antiplatelet medication].
Navarro JL; Frade FJ; Alava I; Obispo T; Trejo R; Jiménez C; Cesar J
Sangre (Barc); 1984; 29(4-C):817-32. PubMed ID: 6096974
[No Abstract] [Full Text] [Related]
3. Biological actions of prostacyclin and its pharmacological use in platelet studies.
Moncada S; Whittle BJ
Adv Exp Med Biol; 1985; 192():337-58. PubMed ID: 3010671
[No Abstract] [Full Text] [Related]
4. [Molecular action of drugs affecting platelet functions (author's transl)].
Verstraete M
Rev Med Brux; 1981 Mar; 2(3):301-8. PubMed ID: 6262895
[No Abstract] [Full Text] [Related]
5. [Status and trends in the field of inhibitors of thrombocyte function].
Glusa E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):575-9. PubMed ID: 6083929
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.
Hornby EJ; Foster MR; McCabe PJ; Stratton LE
Thromb Haemost; 1989 Jun; 61(3):429-36. PubMed ID: 2529661
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
8. Platelet adhesion and signaling induced by the octapeptide primary binding sequence (KOGEOGPK) from type III collagen.
Maurice P; Legrand C; Fauvel-Lafeve F
FASEB J; 2004 Sep; 18(12):1339-47. PubMed ID: 15333577
[TBL] [Abstract][Full Text] [Related]
9. Modulation of human platelet function by prostacyclin and thromboxane A2.
Gorman RR
Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
[No Abstract] [Full Text] [Related]
10. Effect of a collagen derived octapeptide on different steps of the platelet/collagen interaction.
Karniguian A; Legrand YJ; Lefrancier P; Caen JP
Thromb Res; 1983 Dec; 32(6):593-604. PubMed ID: 6320490
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin A1 inhibits increases in intracellular calcium concentration, TXA(2) production and platelet activation.
Zhu Y; Gu ZL; Liang ZQ; Zhang HL; Qin ZH
Acta Pharmacol Sin; 2006 May; 27(5):549-54. PubMed ID: 16626509
[TBL] [Abstract][Full Text] [Related]
12. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA
Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of S-(1,2-dicarboxyethyl)glutathione on collagen-induced platelet aggregation; enhancements of cyclic AMP level and adenylate cyclase activity in platelets by S-(1,2-dicarboxyethyl)glutathione.
Tsuboi S; Fujiwara E; Ogata K; Sakaue A; Nakayama T; Ohmori S
Biol Pharm Bull; 1993 Nov; 16(11):1083-6. PubMed ID: 8312859
[TBL] [Abstract][Full Text] [Related]
14. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclic AMP phosphodiesterase activity of human blood platelet membrane by ADP.
Kahn NN; Sinha AK
Biochim Biophys Acta; 1989 Aug; 984(1):113-8. PubMed ID: 2548620
[TBL] [Abstract][Full Text] [Related]
16. An overview of antiplatelet and antithrombotic drugs.
Verstraete M; Dejana E; Fuster V; Lapetina E; Moncada S; Mustard JF; Tans G; Vargaftig BB
Haemostasis; 1985; 15(2):89-99. PubMed ID: 3159632
[No Abstract] [Full Text] [Related]
17. Inhibition of human platelet aggregation by parathyroid hormone. Is cyclic AMP implicated?
Benigni A; Livio M; Dodesini P; Schieppati A; Panigada M; Mecca G; de Gaetano G; Remuzzi G
Am J Nephrol; 1985; 5(4):243-7. PubMed ID: 2996352
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet drugs.
De Meyer SF; Vanhoorelbeke K; Broos K; Salles II; Deckmyn H
Br J Haematol; 2008 Aug; 142(4):515-28. PubMed ID: 18513285
[TBL] [Abstract][Full Text] [Related]
19. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
20. Complementary roles of glycoprotein VI and alpha2beta1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo.
Kuijpers MJ; Schulte V; Bergmeier W; Lindhout T; Brakebusch C; Offermanns S; Fässler R; Heemskerk JW; Nieswandt B
FASEB J; 2003 Apr; 17(6):685-7. PubMed ID: 12586747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
